Coral-microbialite reefs in pure carbonate versus mixed carbonate-siliciclastic depositional environments: the example of the Pagny-sur-Meuse section (Upper Jurassic,northeastern France)

Middle to Upper Oxfordian reefs of a shallow marine carbonate platform located in northeastern France show important facies changes in conjunction with terrigeneous contents. The Pagny-sur-Meuse section shows coral-microbialite reefs that developed both in pure carbonate limestones and in mixed carbonate-siliciclastic deposits. Phototrophic coral associations dominated in pure carbonate environments, whereas a mixed phototrophic/heterotrophic coral fauna occurred in more siliciclastic settings. Microbialites occur in pure carbonate facies but are more abundant in mixed carbonate-siliciclastic settings. Reefs seem to have lived through periods favourable for intense coral growth that was contemporaneous with a first microbialitic layer and periods more favourable for large microbialitic development (second microbialitic layer). The first microbialitic crust probably developed within the reef body and thus appears to be controlled by autogenic factors. The second generation of microbialites tended to develop over the entire reef surface and was probably mainly controlled by allogenic factors. Variations in terrigeneous input and nutrient content, rather related to climatic conditions than to water depth and accumulation rate, were major factors controlling development of reefs and their taxonomic composition.     

Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo

Destruction of cartilage by matrix metalloproteinases (MMPs) plays a significant role in the pathology of osteoarthritis (OA). A translatable biomarker of MMP activity would enable development of MMP inhibitors for the treatment of OA and potentially the improved diagnosis of OA. A directed approach to identifying specific MMP cleavage products as potential biomarkers has been undertaken. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to identify peptides generated by MMP-driven degradation of human articular cartilage (HAC) in vivo. It was shown that a 45-mer peptide fragment of collagen type II with five hydroxyprolines (OH) can be selectively produced by the activity of collagenase, an enzyme purported to be involved in the pathology of OA. This 45-mer is the most abundant neoepitope peptide found in biological fluids such as urine and synovial fluid. An immunoaffinity LC-MS/MS assay has been developed to quantify collagen type II neoepitope peptides as biomarkers of collagenase modulation. The lower limit of quantification for this assay was established to be 0.035 nM. The assay was used to measure the levels of collagen type II peptides in the urine of both clinical (healthy human subjects) and preclinical species. The urinary levels of the most abundant peptides are reported for rat, rabbit, guinea pig, dog, and healthy human adult subjects. The utility of this peptide to monitor collagenase activity in vivo has been demonstrated through its detailed characterization in HAC explants as well as in the urine of human and other preclinical species.